期刊簡介預計審稿時間： 16 Weeks

Liver cancer has a very high prevalence among cancers in general and is one of the most common causes of death worldwide. Based on these facts, the journal ‘Liver Cancer’ serves the growing need to better understand the causes, mechanisms and therapy of the malignancy. It provides the international community of researchers and clinicians with a platform for their research results, focusing on molecular carcinogenesis, prevention, surveillance, diagnosis and treatment, including molecular targeted therapy, of the disease. 'Liver Cancer' publishes clinical and translational research related to the field of liver cancer in both humans and experimental models in the form of original and review articles.

肝癌在癌癥中發病率極高，是全球最常見的死亡原因之一。基于這些事實，《肝癌》雜志滿足了人們日益增長的需求，讓人們更好地了解這種惡性腫瘤的病因、機制和治療方法。它為國際研究人員和臨床醫生提供了一個平臺，展示他們的研究成果，重點關注該疾病的分子致癌作用、預防、監測、診斷和治療，包括分子靶向治療。《肝癌》以原創和評論文章的形式發表與人類和實驗模型肝癌領域相關的臨床和轉化研究。

《Liver Cancer》(肝癌)編輯部通訊方式為ALLSCHWILERSTRASSE 10, BASEL, SWITZERLAND, CH-4009。如果您需要協助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節省您的寶貴時間，有效提升發表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內容。